The 21,000-dalton protein (p21) encoded by the ras oncogene of Harvey murine sarcoma virus (v-Ha-ras) becomes phosphorylated (pp2l) in vivo and in vitro on threonine residue 59. p21 molecules encoded by cellular ras genes (c-Ha-ras-l) contain an alanine at position 59, and thus these p21 molecules are not phosphorylated. In this investigation, recombinant ras genes have been constructed between the 5' p21 coding region of normal (EC) or oncogenically activated (EJ) human c-Ha-ras-1 and the 3' p21 coding region of v-Haras to generate p21 molecules containing a threonine phosphoacceptor site at position 59 and a glycine (EC/v-Ha) or valine (EJ/v-Ha) at residue 12. In transformed NIH 3T3 mouse fibroblast cells labeled with [35S]methionine, the ratio of pp2l to p21 was strikingly modulated by the amino acid at residue 12. v-Ha-ras p21 has an arginine at position 12, and 24% of total p21 was in the phosphorylated form. A glycine at residue 12 decreased the amount of pp21 to 14% of total p21, and a valine at residue 12 dramatically increased this value to 50%. In vitro, the valine form of p21 had 2.4-and 2.7-fold greater autophosphorylating activity than the glycine and arginine forms of p21, respectively, using [y-32P]GTP as phosphate donor, but the three p21 species had similar Km values for GTP (0.20-0.27 ,uM). These results indicate that a biochemical activity of p21 distinguishes between previously observed biological differences of normal and activated human ras genes.
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Harvey murine sarcoma virus (Ha-MuSV) transforms cells via a 21,000-dalton protein (p21) encoded by the ras oncogene (v-Ha-ras) (1, 2) . v-Ha-ras p21 becomes phosphorylated in whole cells (3) , interacts with the plasma membrane (4), binds GTP (5, 6) and lipid (7) , and possesses an in vitro autophosphorylating activity using GTP but not ATP as phosphate donor (6) . On NaDodSO4/polyacrylamide gels,
[35S]methionine-labeled v-Ha-ras p21 molecules migrate as doublet bands, and the upper band (pp2l) comigrates with 32P-labeled v-Ha-ras p21 (3) . Phosphorylation of v-Ha-ras p21 in vitro as well as in whole cells occurs on a threonine at residue 59 (8) , and this observation suggests that pp2l formation in whole cells may also be due to GTP-specific autophosphorylation. The p21 molecules encoded by rat and human cellular ras (c-Ha-ras-1) also bind GTP (ref. 9 ; unpublished observation). However, c-Ha-ras-1 p21 does not autophosphorylate because an alanine is at residue 59 (9, 10) .
Cell transformation by a p21-mediated mechanism can occur by increasing the intracellular levels of v-Ha-ras p21 or normal c-Ha-ras-1 p21 using the Ha-MuSV long terminal repeat (LTR) promoter (11, 12) . However, if low levels of p21 are expressed in cells, normal c-Ha-ras-1 p21 does not transform cells unless the c-Ha-ras-1 gene is oncogenically activated by point mutations that cause changes in the p21 primary structure (13) (14) (15) (16) (17) . One such mutation changes a glycine at residue 12 of normal human (EC) p21 to a valine in activated human (EJ) p21 (13) . Although EJ p21 and EC p21 have slightly different electrophoretic mobilities on NaDodSO4/ polyacrylamide gels and thus might have different conformations, it is not known whether the valine substitution for glycine at residue 12 alters any biochemical properties of p21. In this report, we demonstrate that v-Ha-ras p21 has greater autophosphorylating activity with a valine at residue 12 than with a glycine.
MATERIALS AND METHODS
DNA Biochemistry and Cloning. The DNA clones used were HB-11 (12), 1-6 (2), EC (11, 13) , and EJ (13, 18) . Restriction enzymes were obtained from New England BioLabs or Boehringer Mannheim. Restriction endonuclease reactions were done at 37°C for 2-5 hr with 5-12 units of enzyme per ,ug of DNA in buffer containing 60 mM NaCl, 6 mM MgCl2, 6 mM Tris.HCl (pH 7.5), 5 mM dithiothreitol, and 0.1 mg of bovine serum albumin per ml. DNA fragments were isolated after 0.8% agarose gel electrophoresis (19) or 5% polyacrylamide gel electrophoresis (20) . Ligation between a 178-base-pair (bp) Pvu II-Pvu II c-Ha-ras-1 fragment (1 ,ug) and a 1400-bp Pvu II-EcoRI v-Ha-ras fragment (3 ,g) was done at 12°C for 2 hr in a 20-,l reaction containing 1600 units of T4 DNA ligase (New England BioLabs) and the supplier's recommended buffer. All other ligation reactions were done with equimolar DNA 5' termini in a 5-,lI reaction containing 400 units of T4 DNA ligase for 14-16 hr at 12°C.
Calcium-shocked Escherichia coli (strain RR-1) were transformed with DNA, and ampicillin-resistant colonies were screened by colony hybridization using 32P-labeled Haras DNA (5-10 x 107 cpm/,ug of DNA) prepared by nicktranslation (see ref. 21 for procedures). Plasmid DNA was prepared by the method of Birnboim and Doly (22) . DNA was transfected onto NIH 3T3 cells after calcium precipitation (23) as described (24) (3, 9) . Cells were lysed in the culture plate for 10-30 min at 4°C with buffer A (1% Triton X-100/0.5% sodium deoxycholate/0.1% NaDodSO4/100 mM NaCl/1 mM EDTA/10 mM sodium phosphate, pH 8.0) containing 1 mM dithiothreitol and 1% (vol/vol) kallikrein inactivator (Calbiochem), and a supernatant fraction was obtained after centrifugation at 100,000 x g for 30 min at 4°C. Immunoprecipitation of p21 molecules with the Ha-ras p21-specific antibodies 238 and 172 (25) plex with an aliquot of cell lysate for 1-2 hr at 40C. The immune complex was subjected to NaDodSO4/polyacrylamide gel electrophoresis on 12% acrylamide gels as described (5 Ampicillin-resistant transformants were first screened with 32P-labeled Ha-ras probe, colony purified, and rescreened using the 178-bp Pvu II-Pvu II EJ fragment as 32p_ labeled probe to ensure the presence of the human c-Ha-ras-1 fragment in the cloned recombinant DNA. Clones containing one c-Ha-ras-1 fragment ligated to the v-Ha-ras fragment in the correct orientation were selected by Pst I digestion and by double digestion with Apa I and Pst I (see Fig. 1 ). Large-scale plasmid preparations were made of the appropriate EC/v-Ha and EJ/v-Ha recombinants, and the identity of the constructions was verified again by (i) Apa I plus Pst I digestion and (ii) Pvu II digestion to detect the presence of the 178-bp c-Ha-ras-1 fragment and Nae I digestion to distinguish the EC fragment from the EJ fragment.
To express the recombinant ras molecules in NIH 3T3 mouse fibroblast cells, we chose to ligate the strong LTR promoter of the subgenomic Ha-MuSV clone 1-6 (2) upstream from the p21 coding region. Clone 1-6 by itself does not transform NIH 3T3 cells (2) . Also, clone 1-6 contains a previously unreported unique Apa I restriction site -700 bp 3' to the LTR that was used to ligate the promoter to the ras sequences. The recombinant ras DNA molecules were digested at the unique Apa I site that is 66 bp 5' to the p21 start codon (10, 13) and then were ligated to Apa I-digested clone 1-6. As a positive control, the subgenomic Ha-MuSV clone HB-11 (see Fig. 1 ), which contains the entire p21 coding sequence but lacks the LTR promoter, was also ligated to clone 1-6 at the Apa I site. The results in Fig. 2 show that EC/v-Ha and EJ/v-Ha ras DNA encode p21 molecules that are dramatically different from each other.
[35S]Methionine-labeled p21 encoded by EC/v-Ha (Fig. 2A, lane 2, and Fig. 2B, lanes 1-3) (Fig. 2C, lane 2) . In contrast to EC/v-Ha p21, the p21 encoded by EJ/v-Ha has a prominent pp2i form in [35S]methionine-labeled cells (Fig. 2A, lane 3, and Fig. 2B , lanes [4] [5] [6] and in [32P]orthophosphate-labeled cells (Fig. 2C, lane 3) . The intensity of [35S]methionine-labeled EJ/v-Ha pp2l is -50-150% of that observed in the lower p21 form. v-Ha p21 (Fig. 2A, lane 5, Fig. 2B, lanes 7-9, and Fig. 2C , lane 5) was observed to have a relative amount of pp2l that is intermediate between EC/v-Ha p21 and EJ/v-Ha p21. In Fig. 2 , no upper band or 32p incorporation was observed for EC p21 or EJ p21 as demonstrated previously (11, 13) because these cellular p21 homologues have alanine at residue 59 and not the threonine phosphoacceptor. Also, no Ha-ras p21 was detected in control NIH 3T3 cells. In addition to the dramatically different pp21/p21 ratios seen in Fig. 2 , it was also consistently observed that the different p21 species displayed subtle differences in their electrophoretic mobilities on NaDodSO4/polyacrylamide gels with the following rank order: EC > EC/v-Ha > v-Ha 2 EJ > EJ/v-Ha. Results identical to those in Fig. 2 The distribution of the upper and lower bands for the different p21 molecules as detected by [35S]methionine labeling was quantitated by densitometry, and the results are summarized in Table 1 . The data clearly show that under steadystate conditions, EJ/v-Ha p21 is almost equally distributed between phosphorylated and unphosphorylated forms, whereas EC/v-Ha p21 and v-Ha p21 exist primarily in the unphosphorylated form. The relative amount of pp2l varies among experiments, especially for EJ/v-Ha p21, and the reasons for this variability are not known. However, it is consistently observed that pp2l formation always has the following rank order: EJ/v-Ha > v-Ha > EC/v-Ha. In addition to the data obtained by metabolic labeling, identical results on steady-state levels of nonradiolabeled p21 and pp2l were obtained by electrophoretic transfer blotting (26) using a monoclonal antibody to p21 (data not shown).
In Vitro Autophosphorylating Activity of Recombinant p21 Molecules. v-Ha p21 autophosphorylates in vitro using GTP specifically as substrate and thus it was necessary to test whether EC/v-Ha p21 and EJ/v-Ha p21 were also capable of undergoing this reaction. The results in Fig. 3 demonstrate that EC/v-Ha p21 and EJ/v-Ha p21 autophosphorylate in vitro in a manner similar to that observed for v-Ha p21; however, the rate of autophosphorylation for EJ/v-Ha p21 is greater than the rates of autophosphorylation for EC/v-Ha p21 or v-Ha p21. In this experiment, EC/v-Ha p21 autophosphorylation was greater than that observed for v-Ha p21, but 107 acid-insoluble cpm) were immunoprecipitated with the Ha-ras p21-specific monoclonal antibody 238 or 172, and p21 was analyzed by NaDodSO4/polyacrylamide gel electrophoresis and autoradiography. The p21 and pp2l bands were quantitated by densitometry, and the areas of the two bands were compared. Data are the mean ± SEM of seven immunoprecipitations utilizing lysates from at least two metabolic labeling experiments and from three independent foci within each sample group.
we have also observed v-Ha p21 autophosphorylation to be greater than EC/v-Ha p21 autophosphorylation (see Fig. 4 Inset). Although v-Ha pp2l formation in whole cells is greater than EC/v-Ha pp2l formation, our in vitro determinations have not resolved whether v-Ha p21 also has greater autophosphorylating activity than EC/v-Ha p21. In three experiments using different p21 preparations, the autophosphorylation of EJ/v-Ha p21 (average ± SD of 15 determinations) was 2.4 + 0.5-fold and 2.7 ± 1.4-fold greater than the autophosphorylation of EC/v-Ha p21 and v-Ha p21, respectively. Under these assay conditions, EC and EJ p21 molecules do not autophosphorylate (data not shown).
The data in Fig. 3 Phosphorylation of p21 was quantitated after NaDodSO4/polyacrylamide gel electrophoresis, autoradiography, and Cerenkov counting of the excised pp2l band. Substrate-velocity kinetics of p21 autophosphorylating activity (Inset) were analyzed by a LineweaverBurk plot to determine Km values for GTP. The velocity (V) of p21 autophosphorylating activity is expressed as fmol of phosphate per pmol of p21 per hr as described in the legend to Fig. 3 One mechanism by which v-Ha, EC/v-Ha, and EJ/v-Ha p21 molecules could have different relative amounts of pp2l and different autophosphorylation rates is by having altered affinities for GTP. The results in Fig. 4 argue against this possibility because all three p21 species have similar apparent Km values for GTP. However, small differences due to a Km change cannot be excluded by these data. When p21 autophosphorylating activity is measured as a function of GTP concentration, the reaction velocity is near maximal at GTP concentrations >1 ,uM (Fig. 4 Inset) . Lineweaver-Burk analysis of these data generates a straight line indicating a single Km for GTP with v-Ha p21 (0.20 AsM), EC/v-Ha p21 (0.27 ,uM), and EJ/v-Ha p21 (0. 20 ,uM) . These values agree with the Km for GTP (=0.2 ,M) with partially purified v-Haras p21 assayed in solution rather than bound in an immunoprecipitate (6).
DISCUSSION
Although the ras genes constructed in this study with the particular combinations of amino acids at residues 12 and 59 have not been described in normal or cancer cells, the differences observed for the p21 molecules encoded by these recombinant ras genes demonstrate that biochemical distinctions exist between the p21 with glycine at position 12 and the activated p21 with valine at position 12. In addition, the ability of the valine, glycine, and arginine forms of p21 to use GTP as substrate strengthens the hypothesis that p21 interBiochemistry: Gibbs et aL action with GTP is important for p21-mediated cell transformation.
It is clear that p21 autophosphorylation is not necessarily required for cell-transforming activity because c-Ha-ras-1 p21 is not phosphorylated but can transform cells. Therefore, the differences in p21 phosphorylation observed in this study cannot per se be directly correlated to the qualitatively different oncogenic properties of human cellular ras genes. It is very possible that p21-mediated cell transformation is due to specific protein kinase activity and that residue 12 affects this kinase activity; however, previous experiments (6) have been unable to demonstrate trans-kinase activity using substrates such as histone, casein, phosvitin, and a tyrosine phosphoacceptor peptide. Thus, we suggest that the autophosphorylation of p21 may be a marker for some other activity of p21. Such an activity probably would involve GTP hydrolysis (for example, GTPase activity). If this idea were true, then the altered phosphorylation of recombinant ras p21 molecules in this study would reflect changes in this speculated activity.
Before we can definitively correlate the biochemical differences of p21 molecules with oncogenic potential, it will be necessary to make other mutations not only at residue 12 but also at residue 61 because position 61 is another site at which activation mutations have been observed in human ras oncogenes (16, 27 ). An important prediction of the biochemical results in this study is that a p21 molecule with valine at position 12 is a more potent protein for cell transformation than a p21 molecule with arginine at position 12 because the valine form of p21 is more active biochemically than the arginine form of p21. However, the current in vitro assay cannot distinguish unambiguously glycine from arginine at position 12 and assay refinements will be necessary to extend the biological significance of the data.
